Tags
- 24 Weeks
- 2B
- 3
- 6
- 6.1
- A
- A1C
- Accompaniment
- Acro
- Across
- Adverse
- Adverse effect
- Adverse event
- Adverse Events
- Allele
- All of us
- Among Others
- An
- ANGPTL3
- Apolipoprotein
- Apolipoprotein B
- Apparent
- Artery
- Artery disease
- Atherosclerosis
- Balance
- Based on
- Baseline
- Benefit
- Benefits
- Biobank
- Blocking
- Blood lipids
- Body
- Body mass index
- Boston
- Cardiology
- Cardiovascular disease
- Cholesterol
- Cholesterol levels
- Circulatory System
- Clinical endpoint
- Clinical trial
- Combination
- Combined hyperlipidemia
- Compulsion
- Concentration
- Consistency
- Content
- Coronary
- Coronary artery disease
- Coronary circulation
- Critical
- Data
- Death
- Decrease
- Development
- Diabetes
- Diabetes mellitus type 2
- Disease
- Diverse
- Diverse population
- Division
- Division of cardiology
- Dose
- Dose–response relationship
- Drug
- Durable
- Dyslipidemia
- EAS
- Editorial
- Effect
- Efficacy
- Elevated
- Enabling
- Endothelial lipase
- Endothelium
- Endpoint
- England
- Enrollment
- Ethnic group
- European
- Evidence
- Experienced
- Expression
- Familial
- Familial hypercholesterolemia
- Fasting
- Fat
- Fat content
- Fatty liver
- Follow-up
- France
- From One
- Gateway Center
- General Hospital
- Gene silencing
- Genetic
- Genetics
- Gram per litre
- Greater
- Harvard Medical School
- HDL
- Health
- Health system
- High-density lipoprotein
- Highlight
- Highlights
- Hospital
- Human body weight
- Human genetics
- Hypercholesterolemia
- Hyperlipidemia
- Inclusive
- Index
- Index, Washington
- Inequality
- Inhibitor
- Injection
- In-phase and quadrature components
- Inserm
- Intentionally
- Interference
- Investigator
- Journal
- Journal of Medicine
- Laboratory
- LDL
- Least squares
- Less
- Levels
- Lille
- Lipase
- Lipid
- Lipoprotein
- Liver
- Liver disease
- Low-density lipoprotein
- Mass
- Massachusett
- Massachusetts
- Massachusetts General Hospital
- Mass index
- Massive
- Mathematical optimization
- M.D.
- Mean difference
- Mechanism
- Medical
- Medical school
- Medicine
- Metabolism
- Mirrored
- Mitt Romney presidential campaign, 2012
- Mixed
- Mount Sinai
- Mount Sinai Health System
- Mutation
- Natarajan Md
- National Institute
- National Institutes of Health
- New
- New York
- New York City
- No
- Open-label trial
- Oregon Route 200
- P
- Participation
- Pasteur
- Pasteur Institute
- Patient
- Percentage
- Pharmacovigilance
- Phase
- PHASE 2
- Phase 3
- PHD
- Placebo
- Platelet
- Pointed
- Population
- Positive
- Positive effect
- Pradeep Natarajan
- Prevalence
- Primary
- Production
- Profile
- Proportion
- Protein
- Publishing
- Race
- Randomness
- Range
- Ranged weapon
- Reducing
- Reduction
- Reductions
- Regulate
- Relative change and difference
- Remnant
- Remnant cholesterol
- Reporting
- Research
- Research program
- Residual
- Resolved
- Result
- Retained firefighter
- Risk
- Rna Wa
- Run-in
- Run-in period
- Safety
- Scale
- School
- Search
- Serious adverse event
- Serum
- Session
- Shown
- Silencing
- Simultaneity
- Stable
- Statin
- Steatosis
- Study skills
- Substance
- Substantial
- Target
- Targets
- The Colourist
- The division
- The european
- The Expression
- The Mechanism
- The Mount
- Then
- The national
- Therapy
- The trial
- Three
- Tithe
- Treat
- Treatment and control groups
- Trial
- Triglyceride
- Triglyceride level
- Type 2
- UMR
- University
- University of Lille
- Unprecedented
- Variant
- Who
- Women
- Zygosity